跳至主要内容
临床试验/NCT05881824
NCT05881824已完成不适用

PAP Treatment Adherence Supported by Dietary Intervention Isimproved in Overweight and Obese Obstructive Sleep Apnea(OSA) Patients: A Randomized, Controlled Trial

University of Crete2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2021年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
74
试验地点
2
主要终点
Difference in PAP adherence

研究概览

简要总结

The aim of this study is to explore the role of diet/lifestyle intervention on Positive airway pressure (PAP) treatment adherence in patients with obstructive sleep apnea (OSA).Specifically, we evaluated the effects of a combination of PAP and weight-loss Mediterranean diet intervention on improving PAP adherence, Body mass index (ΒΜΙ), daytime symptoms, mainly sleepiness and arterial blood pressure measurements over the effect of standard care alone.

详细描述

We designed a parallel, randomized, controlled, clinical trial. Eligible participants are adult, overweight and obese men and women, diagnosed with moderate-to-severe OSA [apnea-hypopnea index (AHI)≥15 events/h] through an attended overnight polysomnography. Participants, after written informed consent, were blindly randomized to a standard care group (SCG, n=37) and a Mediterranean diet group (MDG, n=37). Study groups were prescribed PAP. The SCG received oral healthy lifestyle advice and counseling on physical activity and sleep habits, while the MDG was additionally subjected to a 6-month behavioral intervention aiming at weight loss and increasing adherence to the Mediterranean diet. PAP adherence (hours of device use), BMI, daytime sleepiness, evaluated by Epworth Sleepiness Scale (ESS) and arterial blood pressure measurements were evaluated pre- and post-intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged >18 years with newly diagnosed moderate to severe OSA [apnea-hypopnea index (AHI)≥15 events/h] through an attended overnight polysomnographyaccording to standard criteria
  • overweight and obese [BMI>25 kg/m2]
  • eligible for PAP treatment with adherence data available in the 6-months after initiation of treatment and
  • with an above-elementary school education.

排除标准

  • refusal to participate
  • patients on PAP treatment
  • current participation in a weight loss program
  • central sleep apnea syndromes
  • obesity hypoventilation syndrome
  • restrictive ventilator syndromes
  • severe congestive heart failure
  • a history of life-threatening arrhythmias
  • severe cardiomyopathy
  • long-term oxygen therapy
  • chronic kidney disease
  • family or personal history of mental illness
  • drug or alcohol abuse
  • severe cognitive impairment
  • concurrent oncological diseases
  • pregnancy or lactatio
  • recent hospitalization for acute or chronic respiratory disease
  • history of narcolepsy or restless leg syndrome

结局指标

主要结局

Difference in PAP adherence

时间窗: 6 months

Difference pre post in PAP adherence (hours of device use)

次要结局

  • Difference in Body mass index(6 months)
  • Difference in Blood pressure measurements(6 months)
  • Difference in daytime sleepiness(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Izolde Bouloukaki

Clinical Researcher

University of Crete

研究点 (2)

Loading locations...

相似试验